{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:13:26Z","timestamp":1774743206895,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ind J Clin Biochem"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s12291-023-01124-5","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T19:02:41Z","timestamp":1677870161000},"page":"401-407","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of Bone Turnover Markers in Patients with Acute and Chronic Leukemia"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5559-4198","authenticated-orcid":false,"given":"Reem A.","family":"Al-Qaisi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6347-0451","authenticated-orcid":false,"given":"Abdulnasser M.","family":"Al-Gebori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8521-5876","authenticated-orcid":false,"given":"Mohammed Hadi Munshed","family":"Alosami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"issue":"20","key":"1124_CR1","doi-asserted-by":"publisher","first-page":"7597","DOI":"10.3390\/ijms21207597","volume":"21","author":"J Jann","year":"2020","unstructured":"Jann J, Gascon S, Roux S, Faucheux N. Influence of the TGF-\u03b2 superfamily on osteoclasts\/osteoblasts balance in physiological and pathological bone conditions. Int J Mol Sci. 2020;21(20):7597.","journal-title":"Int J Mol Sci."},{"issue":"9","key":"1124_CR2","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.3390\/cells9092073","volume":"9","author":"JM Kim","year":"2020","unstructured":"Kim JM, Lin C, Stavre Z, Greenblatt MB, Shim JH. Osteoblast\u2013osteoclast communication and bone homeostasis. Cells. 2020;9(9):2073.","journal-title":"Cells"},{"issue":"1","key":"1124_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6065\/apem.2020.25.1.1","volume":"25","author":"MB Ahn","year":"2020","unstructured":"Ahn MB, Suh BK. Bone morbidity in pediatric acute lymphoblastic leukemia. Ann Pediatr Endocrinol Metab. 2020;25(1):1\u20139.","journal-title":"Ann Pediatr Endocrinol Metab."},{"issue":"7","key":"1124_CR4","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.leukres.2013.02.005","volume":"37","author":"E Berman","year":"2013","unstructured":"Berman E, Girotra M, Cheng C, Chanel S, Maki R, Shelat M, et al. Effect of long term imatinib on bone in adults with chronic myelogenous leukemia and gastrointestinal stromal tumors. Leuk Res. 2013;37(7):790\u20134.","journal-title":"Leuk Res."},{"issue":"4","key":"1124_CR5","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1182\/blood-2009-08-237404","volume":"115","author":"K Vandyke","year":"2010","unstructured":"Vandyke K, Fitter S, Dewar AL, Hughes TP, Zannettino ACW. Dysregulation of bone remodeling by imatinib mesylate. Blood. 2010;115(4):766\u201374.","journal-title":"Blood"},{"issue":"4","key":"1124_CR6","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1210\/jc.2008-2324","volume":"94","author":"S O\u2019Sullivan","year":"2009","unstructured":"O\u2019Sullivan S, Horne A, Wattie D, Porteous F, Callon K, Gamble G, et al. Decreased bone turnover despite persistent secondary hyperparathyroidism during prolonged treatment with imatinib. J Clin Endocrinol Metab. 2009;94(4):1131\u20136.","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"1124_CR7","first-page":"721","volume":"18","author":"BA Sophia Jaeger","year":"2012","unstructured":"Sophia Jaeger BA, Tauer JT, Ulmer A, Kuhlisch E, Roth HJ, Suttorp M. Changes in bone metabolic parameters in children with chronic myeloid leukemia on imatinib treatment. Med Sci Monit. 2012;18(12):721\u20138.","journal-title":"Med Sci Monit."},{"issue":"10","key":"1124_CR8","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.3324\/haematol.2019.231456","volume":"106","author":"P Giannoni","year":"2021","unstructured":"Giannoni P, Marini C, Cutrona G, Matis S, Capra MC, Puglisi F, et al. Chronic lymphocytic leukemia cells impair osteoblastogenesis and promote osteoclastogenesis: role of TNF\u03b1, IL-6 and IL-11 cytokines. Haematologica. 2021;106(10):2598.","journal-title":"Haematologica"},{"issue":"20","key":"1124_CR9","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.1182\/bloodadvances.2020001808","volume":"4","author":"Y Chen","year":"2020","unstructured":"Chen Y, Hoffmeister LM, Zaun Y, Arnold L, Schmid KW, Giebel B, et al. Acute myeloid leukemia\u2013induced remodeling of the human bone marrow niche predicts clinical outcome. Blood Adv. 2020;4(20):5257\u201368.","journal-title":"Blood Adv"},{"issue":"3","key":"1124_CR10","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3324\/haematol.2020.247205","volume":"106","author":"A Pievani","year":"2021","unstructured":"Pievani A, Donsante S, Tomasoni C, Corsi A, Dazzi F, Biondi A, et al. Acute myeloid leukemia shapes the bone marrow stromal niche in vivo. Haematologica. 2021;106(3):865\u201370.","journal-title":"Haematologica"},{"issue":"1","key":"1124_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40364-017-0097-4","volume":"5","author":"T-R Kuo","year":"2017","unstructured":"Kuo T-R, Chen C-H. Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives. Biomark Res. 2017;5(1):1\u20139.","journal-title":"Biomark Res."},{"issue":"2","key":"1124_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1158\/0008-5472.CAN-12-2280","volume":"73","author":"BJ Schmiedel","year":"2013","unstructured":"Schmiedel BJ, Scheible CA, Nuebling T, Kopp HG, Wirths S, Azuma M, et al. RANKL expression, function, and therapeutic targeting in multiple myeloma and chronic lymphocytic leukemia. Cancer Res. 2013;73(2):683\u201394.","journal-title":"Cancer Res"},{"issue":"10","key":"1124_CR13","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.3109\/10428194.2016.1151506","volume":"57","author":"M Borge","year":"2016","unstructured":"Borge M, Delpino MV, Podaza E, Stanganelli C, Palau-Nagore V, Roisman A, et al. Soluble RANKL production by leukemic cells in a case of chronic lymphocytic leukemia with bone destruction. Leuk Lymphoma. 2016;57(10):2468\u201371.","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"1124_CR14","first-page":"3121","volume":"83","author":"PM Crofton","year":"1998","unstructured":"Crofton PM, Ahmed SF, Wade JC, Stephen R, Elmlinger MW, Ranke MB, et al. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia. J Clin Endocrinol Metab. 1998;83(9):3121\u20139.","journal-title":"J Clin Endocrinol Metab."},{"issue":"18","key":"1124_CR15","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1182\/blood-2013-07-517219","volume":"124","author":"M Krevvata","year":"2014","unstructured":"Krevvata M, Silva BC, Manavalan JS, Galan-Diez M, Kode A, Matthews BG, et al. Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts. Blood. 2014;124(18):2834\u201346.","journal-title":"Blood"},{"issue":"2","key":"1124_CR16","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1182\/blood-2011-04-348151","volume":"119","author":"BJ Frisch","year":"2012","unstructured":"Frisch BJ, Ashton JM, Xing L, Becker MW, Jordan CT, Calvi LM. Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia. Blood. 2012;119(2):540\u201350.","journal-title":"Blood"},{"issue":"7","key":"1124_CR17","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/cncr.22546","volume":"109","author":"A Sala","year":"2007","unstructured":"Sala A, Barr RD. Osteopenia and cancer in children and adolescents: the fragility of success. Cancer. 2007;109(7):1420\u201331.","journal-title":"Cancer"},{"issue":"6","key":"1124_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0131192","volume":"10","author":"JT Tauer","year":"2015","unstructured":"Tauer JT, Hofbauer LC, Jung R, Gerdes S, Glauche I, Erben RG, et al. Impact of long-term exposure to the tyrosine kinase inhibitor imatinib on the skeleton of growing rats. PLoS ONE. 2015;10(6):1\u201317.","journal-title":"PLoS ONE"},{"issue":"3","key":"1124_CR19","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/leu.2015.325","volume":"30","author":"S Geyh","year":"2016","unstructured":"Geyh S, Rodr\u00edguez-Paredes M, J\u00e4ger P, Khandanpour C, Cadeddu RP, Gutekunst J, et al. Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia. Leukemia. 2016;30(3):683\u201391.","journal-title":"Leukemia"},{"issue":"4","key":"1124_CR20","first-page":"1215","volume":"100","author":"A Ferrajoli","year":"2002","unstructured":"Ferrajoli A, Keating MJ, Manshouri T, Giles FJ, Dey A, Estrov Z, et al. The clinical significance of tumor necrosis factor-\u03b1 plasma level in patients having chronic lymphocytic leukemia. Blood J Am Soc Hematol. 2002;100(4):1215\u20139.","journal-title":"Blood J Am Soc Hematol."},{"key":"1124_CR21","first-page":"1","volume":"2015","author":"GC Yang","year":"2015","unstructured":"Yang GC, Xu YH, Chen HX, Wang XJ. Acute lymphoblastic leukemia cells inhibit the differentiation of bone mesenchymal stem cells into osteoblasts in vitro by activating notch signaling. Stem Cells Int. 2015;2015:1\u201312.","journal-title":"Stem Cells Int."},{"issue":"4","key":"1124_CR22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/10245330500155598","volume":"10","author":"MA El-Ziny","year":"2005","unstructured":"El-Ziny MA, Al-Tonbary YA, Salama OS, Bakr AA, Al-Marsafawy H, Elsharkawy AA. Low turnover bone disease in Egyptian children with acute leukemia. Hematology. 2005;10(4):327\u201333.","journal-title":"Hematology"},{"issue":"4","key":"1124_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0022-3476(95)70349-7","volume":"126","author":"JM Halton","year":"1995","unstructured":"Halton JM, Atkinson SA, Fraher L, Webber CE, Cockshott WP, Tam C, et al. Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia. J Pediatr. 1995;126(4):557\u201364.","journal-title":"J Pediatr."},{"issue":"4","key":"1124_CR24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.exphem.2008.12.008","volume":"37","author":"D Tibullo","year":"2009","unstructured":"Tibullo D, Giallongo C, La Cava P, Berretta S, Stagno F, Chiarenza A, et al. Effects of imatinib mesylate in osteoblastogenesis. Exp Hematol. 2009;37(4):461\u20138.","journal-title":"Exp Hematol."},{"issue":"1","key":"1124_CR25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.sjbs.2014.09.002","volume":"22","author":"M Rasool","year":"2015","unstructured":"Rasool M, Farooq S, Malik A, Shaukat A, Manan A, Asif M, et al. Assessment of circulating biochemical markers and antioxidative status in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) patients. Saudi J Biol Sci. 2015;22(1):106\u201311.","journal-title":"Saudi J Biol Sci."},{"issue":"3","key":"1124_CR26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.36347\/sjams.2021.v09i03.019","volume":"9","author":"A Yadav","year":"2021","unstructured":"Yadav A, Yadav M. Bone health in patients of chronic myeloid leukemia on imatinib therapy. Sch J Appl Med Sci. 2021;9(3):390\u20132.","journal-title":"Sch J Appl Med Sci."},{"issue":"6","key":"1124_CR27","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1001\/jamaoncol.2018.0613","volume":"4","author":"A Gupta","year":"2018","unstructured":"Gupta A, Moore JA. Tumor lysis syndrome. JAMA Oncol. 2018;4(6):895.","journal-title":"JAMA Oncol."},{"issue":"9 Suppl 1","key":"1124_CR28","first-page":"S17","volume":"140","author":"L Paunier","year":"1992","unstructured":"Paunier L. Effect of magnesium on phosphorus and calcium metabolism. Monatsschrift Kinderheilkd Organ der Dtsch Gesellschaft Fur Kinderheilkd. 1992;140(9 Suppl 1):S17-20.","journal-title":"Monatsschrift Kinderheilkd Organ der Dtsch Gesellschaft Fur Kinderheilkd."},{"issue":"6","key":"1124_CR29","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.3390\/nu12061836","volume":"12","author":"J Malinowska","year":"2020","unstructured":"Malinowska J, Ma\u0142ecka M, Ciepiela O. Variations in magnesium concentration are associated with increased mortality: study in an unselected population of hospitalized patients. Nutrients. 2020;12(6):1836.","journal-title":"Nutrients"},{"issue":"1","key":"1124_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-019-0356-0","volume":"17","author":"H Reeh","year":"2019","unstructured":"Reeh H, Rudolph N, Billing U, Christen H, Streif S, Bullinger E, et al. Response to IL-6 trans- A nd IL-6 classic signalling is determined by the ratio of the IL-6 receptor \u03b1 to gp130 expression: fusing experimental insights and dynamic modelling. Cell Commun Signal. 2019;17(1):1\u201321.","journal-title":"Cell Commun Signal."},{"issue":"9","key":"1124_CR31","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/sj.bmt.1700936","volume":"20","author":"M Steffen","year":"1997","unstructured":"Steffen M, Pichlmeier U, Zander A. Inverse correlation of interleukin-6 with soluble interleukin-6 receptor after transplantation of bone marrow or peripheral blood stem cells. Bone Marrow Transpl. 1997;20(9):715\u201320.","journal-title":"Bone Marrow Transpl."},{"key":"1124_CR32","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3389\/fendo.2018.00788","volume":"9","author":"D Harmer","year":"2019","unstructured":"Harmer D, Falank C, Reagan MR. Interleukin-6 interweaves the bone marrow microenvironment, bone loss, and multiple myeloma. Front Endocrinol. 2019;9:788.","journal-title":"Front Endocrinol."},{"issue":"6","key":"1124_CR33","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1002\/jcp.23029","volume":"227","author":"R Ciarcia","year":"2012","unstructured":"Ciarcia R, Vitiello MT, Galdiero M, Pacilio C, Iovane V, D\u2019Angelo D, et al. Imatinib treatment inhibit IL-6, IL-8, NF-KB and AP-1 production and modulate intracellular calcium in CML patients. J Cell Physiol. 2012;227(6):2798\u2013803.","journal-title":"J Cell Physiol"},{"issue":"3","key":"1124_CR34","first-page":"154","volume":"28","author":"MMA Eid","year":"2018","unstructured":"Eid MMA, El Hafeez MMAA, Ellithy HN, Elabdin HMZ, Ezzat GM. Early predictors of suboptimal response to CML therapy could help in determining treatment strategy. UHOD Uluslar Hematol Derg. 2018;28(3):154\u201361.","journal-title":"UHOD Uluslar Hematol Derg."},{"issue":"19","key":"1124_CR35","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1056\/NEJMoa051140","volume":"354","author":"E Berman","year":"2006","unstructured":"Berman E, Nicolaides M, Maki RG, Fleisher M, Chanel S, Scheu K, et al. Altered bone and mineral metabolism in patients receiving imatinib mesylate. N Engl J Med. 2006;354(19):2006\u201313.","journal-title":"N Engl J Med."},{"issue":"1","key":"1124_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"W Feng","year":"2017","unstructured":"Feng W, Liu H, Luo T, Liu D, Du J, Sun J, et al. Combination of IL-6 and sIL-6R differentially regulate varying levels of RANKL-induced osteoclastogenesis through NF-\u03baB, ERK and JNK signaling pathways. Sci Rep. 2017;7(1):1\u201311.","journal-title":"Sci Rep."},{"issue":"11","key":"1124_CR37","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.1210\/jc.2001-011814","volume":"87","author":"IA Nakchbandi","year":"2002","unstructured":"Nakchbandi IA, Mitnick MA, Lang R, Gundberg C, Kinder B, Insogna K. Circulating levels of interleukin-6 soluble receptor predict rates of bone loss in patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 2002;87(11):4946\u201351.","journal-title":"J Clin Endocrinol Metab."}],"container-title":["Indian Journal of Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12291-023-01124-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12291-023-01124-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12291-023-01124-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T23:04:12Z","timestamp":1720739052000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12291-023-01124-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["1124"],"URL":"https:\/\/doi.org\/10.1007\/s12291-023-01124-5","relation":{},"ISSN":["0970-1915","0974-0422"],"issn-type":[{"value":"0970-1915","type":"print"},{"value":"0974-0422","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,3]]},"assertion":[{"value":"13 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All participants agreed to this study, and the approval of the local ethics committee was obtained. There was no specific picture or information we wanted to publish in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}]}}